Qianggan Ruanjian Pill ameliorates liver fibrosis through regulation of the TGF-β1/Smad and PI3K/AKT signalling pathways
Qunying Feng, Qinghua Zhao, Shuaiyong Qu, Yiju Zhao, Kunlun Li, Bo Yuan, Qinzheng Chang, Jingjiang Xu, Hongxia Wang, Yongqin Zhu, Kai Fu, Jingsheng Liu
Topics & Concepts
SMADPI3K/AKT/mTOR pathwayLiver fibrosisPillProtein kinase BSignal transductionMedicineSignallingSignalling pathwaysPharmacologyFibrosisInternal medicineCancer researchEndocrinologyTransforming growth factorTraditional medicineBiologyCell biologyLiver physiology and pathologyLiver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and Protection